NAAS Rating: 5.23 new
“The Pharma Innovation” is committed to upholding the highest standards of publication ethics and takes all possible measures against any publication malpractices. All authors submitting their works to the journal for publication as original articles attest that the submitted works represent their authors’ contributions and have not been copied or plagiarized in whole or in part from other works. The authors acknowledge that they have disclosed all and any actual or potential conflicts of interest with their work or partial benefits associated with it. In the same manner, “The Pharma Innovation” is committed to objective and fair double-blind peer-review of the submitted for publication works and to prevent any actual or potential conflict of interests between the editorial and review personnel and the reviewed material. Any departures from the above-defined rules should be reported directly to the Editors-in-Chief or Director, who is unequivocally committed to providing swift resolutions to any of such a type of problems.
Originality and plagiarism: Authors should ensure that they have written original works. Any work or words of other authors, contributors, or sources (including online sites) should be appropriately credited and referenced.
Further to the above, “The Pharma Innovation” provides a platform for the open public discussion of the journal contents. The website contents will be available without logging but no peer review comments can be posted on the website without the disclosure of the reviewer identity to the journal editors.